Loading clinical trials...
Loading clinical trials...
Assessment of Ventilation-perfusion Abnormalities in Patients With Smoking-related Airways Disease in Stable Condition and the Effect of Bronchodilator Therapy
Subjects undergo history, examination, lung function assessment after informed consent has been obtained. All subjects will undergo ventilation-perfusion scans. If there first scan is normal they will undergo a second and final scan four weeks later. If abnormal they will undergo two further scans with either nebulized bronchodilator or nebulized saline prior to their second and third scans. Each time they will have repeat lung function tests prior to scanning. We will examine the regional changes in ventilation and perfusion and there relationship to lung function.
As in Brief description
Age
35 - 75 years
Sex
ALL
Healthy Volunteers
No
Imperial College Hammersmith Campus
London, London, United Kingdom
Start Date
September 1, 2005
Primary Completion Date
February 1, 2008
Completion Date
February 1, 2008
Last Updated
September 24, 2013
2
ACTUAL participants
salbutamol + ipratropium bromide nebules
DRUG
nebulized saline
DRUG
Lead Sponsor
Imperial College London
Collaborators
NCT07477600
NCT05878769
NCT06717659
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions